These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 1976128)
21. [Current developments in the pharmacology of dopaminergic receptors (I)]. Nechifor M; Lucaci L Rev Med Chir Soc Med Nat Iasi; 1989; 93(1):143-4. PubMed ID: 2573121 [No Abstract] [Full Text] [Related]
22. Medical management of chronic heart failure: inotropic, vasodilator, or inodilator drugs? Lang R Am Heart J; 1990 Dec; 120(6 Pt 2):1558-64. PubMed ID: 1978981 [TBL] [Abstract][Full Text] [Related]
23. Drugs recently released in Belgium. Ibopamine--pravastatin. Harvengt C Acta Clin Belg; 1993; 48(1):54-7. PubMed ID: 8098890 [No Abstract] [Full Text] [Related]
24. Ibopamine in chronic congestive heart failure: hemodynamic and neurohumoral effects. López-Sendón J Am J Med; 1991 May; 90(5B):43S-49S. PubMed ID: 1675551 [TBL] [Abstract][Full Text] [Related]
25. Dopaminergic agents in heart failure: rebirth of an old concept. Remme WJ Cardiovasc Drugs Ther; 2001 Mar; 15(2):107-9. PubMed ID: 11669402 [No Abstract] [Full Text] [Related]
26. Partial brain dopamine D2 receptor agonists in the treatment of schizophrenia. Coward D; Dixon K; Enz A; Shearman G; Urwyler S; White T; Karobath M Psychopharmacol Bull; 1989; 25(3):393-7. PubMed ID: 2576320 [TBL] [Abstract][Full Text] [Related]
27. [Pathophysiology and therapy of malignant neuroleptic syndrome]. Weller M; Kornhuber J Nervenarzt; 1992 Nov; 63(11):645-55. PubMed ID: 1361662 [TBL] [Abstract][Full Text] [Related]
28. Treatment of Parkinson's disease with the partial dopamine agonist EMD 49980. Bravi D; Davis TL; Mouradian MM; Chase TN Mov Disord; 1993 Apr; 8(2):195-7. PubMed ID: 8097280 [TBL] [Abstract][Full Text] [Related]
29. Medications acting on the dopaminergic system in the treatment of alcoholic patients. Swift R Curr Pharm Des; 2010; 16(19):2136-40. PubMed ID: 20482513 [TBL] [Abstract][Full Text] [Related]
30. Inodilation--the way ahead in the early therapy of congestive heart failure? Opie LH Cardiology; 1988; 75 Suppl 1():138-47. PubMed ID: 2853004 [No Abstract] [Full Text] [Related]
31. PHNO, a novel dopamine agonist, in animal models of parkinsonism. Koller W; Herbster G; Gordon J Mov Disord; 1987; 2(3):193-9. PubMed ID: 2904649 [TBL] [Abstract][Full Text] [Related]
32. Identification and characterization of dopamine receptors in the cardiovascular system. Goldberg LI; Kohli JD Cardiologia; 1987 Dec; 32(12):1603-7. PubMed ID: 3447717 [No Abstract] [Full Text] [Related]
34. Role of dopamine receptors and the utility of dopamine agonists in heart failure. Rajfer SI; Davis FR Circulation; 1990 Aug; 82(2 Suppl):I97-102. PubMed ID: 1973645 [TBL] [Abstract][Full Text] [Related]
35. Dopaminergic agonists in the treatment of Parkinson's disease. Goetz CG; Diederich NJ Neurol Clin; 1992 May; 10(2):527-40. PubMed ID: 1350052 [TBL] [Abstract][Full Text] [Related]
36. Administration of inotropes. Davies N Nurs Times; 2001 Jul 19-25; 97(29):36-7. PubMed ID: 11957503 [No Abstract] [Full Text] [Related]
37. [Effect of dopamine on the kidney function in diseases of premature infants]. Tulassay T; Seri I; Machay T; Kiszel J; Csömör S Orv Hetil; 1982 Nov; 123(48):2949-52. PubMed ID: 7155567 [No Abstract] [Full Text] [Related]
38. Current status of dopamine agonists in Parkinson's disease management. Montastruc JL; Rascol O; Senard JM Drugs; 1993 Sep; 46(3):384-393. PubMed ID: 7693430 [TBL] [Abstract][Full Text] [Related]